Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer.

Jarosch, Armin; Sommer, Ulrich; Bogner, Andreas; Reißfelder, Christoph; Weitz, Jürgen; Krause, Mechthild; Folprecht, Gunnar; Baretton, Gustavo B; Aust, Daniela E

Jarosch, Armin; Sommer, Ulrich; Bogner, Andreas; Reißfelder, Christoph; Weitz, Jürgen; Krause, Mechthild; Folprecht, Gunnar; Baretton, Gustavo B; Aust, Daniela E.

Afiliação

Jarosch A; Institute of Pathology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany.
Sommer U; National Center for Tumor Diseases (NCT) partner site Dresden.
Bogner A; Institute of Pathology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany.
Reißfelder C; National Center for Tumor Diseases (NCT) partner site Dresden.
Weitz J; Department for Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany.
Krause M; National Center for Tumor Diseases (NCT) partner site Dresden.
Folprecht G; Department for Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany.
Baretton GB; National Center for Tumor Diseases (NCT) partner site Dresden.
Aust DE; German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Dresden, Germany.